
Aprim Pharmceuticals Private Limited
About Aprim Pharmceuticals Private Limited
Data last updated:
Aprim Pharmceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 13 June 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1994PTC059589. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar Sharma and Jag Mohan Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 National Park Laj Pat Nagar – IV, New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2020, the company reported a revenue of ₹3.44 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹2,436 (net margin 0.7%) and EBITDA of ₹8,104 (EBITDA margin 2.4%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Aprim Pharmceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address62 National Park Laj Pat Nagar – IV, New Delhi, Delhi, India – 110024
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Aprim Pharmceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aprim Pharmceuticals Private Limited
FY 2025 filings availableAprim Pharmceuticals Private Limited reported revenue of ₹3.44 Lakh (down 1% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over three years, including a 1% fall in the latest year. EBITDA rose 65% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹3.44 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,104 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,436 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aprim Pharmceuticals Private Limited, buy the company report.
Board of directors of Aprim Pharmceuticals Private Limited
Aprim Pharmceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Kumar Sharma | Director | 13 Jun 1994 | 32 Years 4 Months | Current |
| Jag Mohan Sharma | Director | 13 Jun 1994 | 32 Years 4 Months | Current |
Auditor
Aprim Pharmceuticals Private Limited is audited by M.M.NARANG AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.M.NARANG AND ASSOCIATES | FY 2017 | 011973N |
Shareholding
The shareholding of Aprim Pharmceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aprim Pharmceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aprim Pharmceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aprim Pharmceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aprim Pharmceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Aprim Pharmceuticals Private Limited, buy the company report.
Recent activity
Aprim Pharmceuticals Private Limited has 2 board changes on record since 1994: 2 appointments. The latest: Jag Mohan Sharma was appointed as Director on 13 Jun 1994.
Frequently asked questions
Aprim Pharmceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 13 June 1994 (32+ years old) and is registered under CIN U74899DL1994PTC059589.
Aprim Pharmceuticals has 2 current directors:
- Rajesh Kumar Sharma - Director
- Jag Mohan Sharma - Director
The latest financial statements of Aprim Pharmceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Aprim Pharmceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Aprim Pharmceuticals is U74899DL1994PTC059589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aprim Pharmceuticals was incorporated on 13 June 1994, making it 32+ years old. It is registered with the Registrar of Companies, Delhi.
Jag Mohan Sharma was appointed as Director on 13 Jun 1994. Rajesh Kumar Sharma was appointed as Director on 13 Jun 1994.
The registered office of Aprim Pharmceuticals is at 62 National Park Laj Pat Nagar – IV, New Delhi, Delhi, India – 110024.
Aprim Pharmceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Aprim Pharmceuticals is compliant as of 30 July 2026. The company is actively filing with the Registrar of Companies.

